Real-time enrollment status for this heart failure and reduced ejection fraction clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:10 PM UTC
| NCT Number | NCT07131631 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure and Reduced Ejection Fraction |
| Phase | Clinical Trial |
| Target Enrollment | 125 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Minneapolis Heart Institute Foundation |
| Last Updated on CT.gov | December 23, 2025 (Dec 23, 2025) |
As of July 13, 2026: Clinical trial NCT07131631 is currently recruiting participants. This clinical trial study for heart failure and reduced ejection fraction is actively seeking new participants at 5 locations across the United States. The study is sponsored by Minneapolis Heart Institute Foundation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07131631 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07131631 was last updated Dec 23, 2025 (December 23, 2025). HelloStudys verifies this status automatically.